Back
Tri Pointe Homes Vs. Corcept Therapeutics Industry Stock Comparison
Buy
68
TPH
Tri Pointe Homes
Last Price:
42.70
Seasonality Move:
6.93%
Buy
87
CORT
Corcept Therapeutics
Last Price:
59.57
Seasonality Move:
3.97%
Buy
68
Tri Pointe Homes (TPH)
is a Buy
Is Tri Pointe Homes a Buy, Sell or Hold?
- The current Tri Pointe Homes [TPH] share price is $42.67. The Score for TPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- TPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
TPH Stock Price Chart
What is Tri Pointe Homes's stock price today?
-
The Tri Pointe Homes share price today is $42.67
The current trend is relatively stagnant and TPH is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
TPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 50.92 | Buy |
| Chaikin Money Flow: | 387427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.89 - 44.57) | Sell |
| Bollinger Bands (100): | (39.47 - 45.27) | Buy |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.95 | Buy |
| Relative Strength Index (14 RSI): | 80.63 | Buy |
| Chaikin Money Flow: | 759215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.11 - 51.89) | Buy |
| Bollinger Bands (100): | (31.7 - 45.68) | Buy |
TPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.32 | Buy |
| 20-day SMA: | 42.52 | Buy |
| 50-day SMA: | 43.39 | Sell |
| 200-day SMA: | 39.49 | Buy |
| 8-day EMA: | 41.78 | Buy |
| 20-day EMA: | 42.23 | Buy |
| 50-day EMA: | 42.75 | Sell |
| 200-day EMA: | 39.55 | Buy |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.72 | Buy |
| 20-day SMA: | 49.28 | Buy |
| 50-day SMA: | 44.07 | Buy |
| 200-day SMA: | 32 | Buy |
| 8-day EMA: | 53.06 | Buy |
| 20-day EMA: | 49.83 | Buy |
| 50-day EMA: | 45.17 | Buy |
| 200-day EMA: | 35.31 | Buy |
Tri Pointe Homes Earnings Growth & TPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.49 per share, and a decrease next year of $0.22 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Tri Pointe Homes Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||